On Jan. 3, blood-testing company Immucor
- Revenues exceeded analyst expectations, rising 24% to $54.4 million.
- Earnings per share also exceeded forecasts as net income rose 75% to $14.1 million.
- Immucor has been able to continue its practice of price increases, leading to increased margins and driving strong earnings growth.
- Immucor has earned a five-star rating at Motley Fool CAPS.
(Figures in thousands, except per-share data)
Income Statement Highlights
|
Avg. Est. |
Q2 2007 |
Q2 2006 |
Change |
|
|---|---|---|---|---|
|
Sales |
$51,400 |
$54,426 |
$44,025 |
23.6% |
|
Net Profit |
-- |
$14,102 |
$8,055 |
75.1% |
|
EPS |
$0.18 |
$0.20 |
$0.11 |
81.8% |
|
Diluted Shares |
70,510* |
71,500 |
(1.4%) |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q2 2007 |
Q2 2006 |
Change* |
|
|---|---|---|---|
|
Gross Margin |
69.53% |
64.83% |
4.70 |
|
Operating Margin |
39.21% |
29.00% |
10.21 |
|
Net Margin |
25.91% |
18.30% |
7.61 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets |
Q2 2007 |
Q2 2006 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$74,523 |
$36,400 |
104.7% |
|
Accounts Rec. |
$41,269 |
$36,922 |
11.8% |
|
Inventory |
$22,615 |
$19,825 |
14.1% |
|
Liabilities |
Q2 2007 |
Q2 2006 |
Change |
|---|---|---|---|
|
Accounts Payable |
$6,307 |
$11,091 |
(43.1%) |
|
Long-Term Debt |
$0 |
$100 |
(100.0%) |
Learn the ways of the balance sheet.
Cash Flow Highlights
A cash flow statement was not included in the press release. Find out why Fools always follow the money.
Related Companies:
- Beckman Coulter (NYSE: BEC)
- Dade Behring (Nasdaq: DADE)
- Thermo Fisher Scientific (NYSE: TMO)
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean.
Don't miss out on the final days of The Motley Fool's annual Foolanthropy fundraising campaign. Five worthy charities are vying for a $10,000 donation from the Fool. Any gift you make will make a difference to someone in need.
At the time of publication, Rich Duprey had no positions in any of the companies mentioned in the article. Fool rules are here.
